Paul Hastings partner Haiyan Tang, who has served as the firm's chief representative in Shanghai, has left the firm to assume an in-house position – a move that follows the departure of Paul Hastings' Beijing chief representative, who recently left for a Chinese firm.

Tang left Paul Hastings last month to join CBC Group, a Shanghai-based private equity firm focused on the healthcare sector, where she will be chief legal and compliance officer and a managing director. Last year, Paul Hastings served as underwriters' counsel on a $400 million Hong Kong listing of CBC's portfolio company Ascletis Pharma Inc.

Tang leaves Paul Hastings after five years with the firm, where she had been a litigation partner since 2015, focusing on government enforcement proceedings, internal investigations, compliance programmes and dispute resolutions. During her time at the firm, she served as acting regional compliance director in China for U.S. drugmaker Pfizer Inc. when it was fulfilling its self-reporting obligations to the U.S. Department of Justice and Securities and Exchange Commission.